XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis

A Deczkowska, E David, P Ramadori, D Pfister… - Nature medicine, 2021 - nature.com
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are
prevalent liver conditions that underlie the development of life-threatening cirrhosis, liver …

XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis

A Deczkowska, E David, P Ramadori… - Nature …, 2021 - weizmann.elsevierpure.com
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are
prevalent liver conditions that underlie the development of life-threatening cirrhosis, liver …

[引用][C] XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis

A Deczkowska, E David, A Giladi, DA Jaitin, O Barboy… - Nature Medicine, 2021 - elibrary.ru

XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis

A Deczkowska, E David… - Nature …, 2021 - weizmann.esploro.exlibrisgroup.com
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are
prevalent liver conditions that underlie the development of life-threatening cirrhosis, liver …

XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis

A Deczkowska, E David… - Nature …, 2021 - … .esploro.exlibrisgroup.com
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are
prevalent liver conditions that underlie the development of life-threatening cirrhosis, liver …

XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis

A Deczkowska, E David, P Ramadori, D Pfister… - Nature Medicine, 2021 - cris.bgu.ac.il
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are
prevalent liver conditions that underlie the development of life-threatening cirrhosis, liver …

XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis

A Deczkowska, E David, P Ramadori, D Pfister… - Nature Medicine, 2021 - hal.science
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are
prevalent liver conditions that underlie the development of life-threatening cirrhosis, liver …

XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis

A Deczkowska, E David, P Ramadori… - Nature …, 2021 - pubmed.ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are
prevalent liver conditions that underlie the development of life-threatening cirrhosis, liver …

XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis

A Deczkowska, E David, P Ramadori, D Pfister… - Nature Medicine, 2021 - zora.uzh.ch
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are
prevalent liver conditions that underlie the development of life-threatening cirrhosis, liver …

[引用][C] XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis

A Deczkowska, E David, P Ramadori, D Pfister… - Nature Medicine, 2021 - cir.nii.ac.jp
XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis
| CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …